SentrX Leadership
Richard K. Koehn, Ph.D.Co-founder, President and CEO
A consultant to the venture capital business for over 12 years, he was Entrepeneur of the Year in 1991. As CEO of Salus Therapeutics, he negotiated it's acquisition by Genta, Inc. In 2005, he negotiated a $7.5M investment in Sentrx Surgical leading to the creation of Carbylan BioSurgery and Sentrx Animal Care. Founding Director of the Center for Advanced Biomedical Technology in NY, VP for Research at the University of Utah (1992-2000), in 2005, Koehn was awarded the Governor's Medal in Science and Technology.
Brenda K. Mann, Ph.D.
Co-founder and COO
B.S. (1991), Chemical Engineering, Iowa State University; Ph.D. (1997), Chemical Engineering, Rice University. Dr. Mann has extensive experience in the development of hydrogels for tissue engineering and wound healing applications. She received the Rice University Outstanding Woman Award in 1996, and the Young Investigator Award from the International Society for Applied Cardiovascular Biology in 2000. Dr. Mann was a founding faculty member of the Keck Graduate Institute of Applied Life Sciences, and now serves on it's Advisory Council. She is a Research Assistant Professor in the Department of Bioengineering at the University of Utah and holds an adjunct faculty position at the University of texas at El Paso. Dr. Mann is also a registered patent agent.
Glenn D. Prestwich, Ph.D.
Co-founder and Senior Scientific Advisor
Presidential Professor of Medicinal Chemistry, The University of Utah (1996-present); B.Sc. (1970), Chemistry, California Institute of Technology; Ph.D. (1974), Chemistry, Stanford University; Alfred P. Sloan Research and Dreyfus Teacher-Scholar Awards; 1998 Paul Dawson Biotechnology Award (AACP); Fellow of American Institute for Medical and Biological Engineering Professor of Chemistry, Stony Brook University (1977-1996); Director, Center for Biotechnology (Stony Brook, 1992-1996); Director, Center for Cell Signaling (2002-2007); Director, Center for Therapeutic Biomaterials (2004-present). Co-founder and former CSO of Eschelon Biosciences, Inc.; co-founder and former CSO, Sentrx Surgical, Inc.; Senior Scientific Advisor, Carbylan BioSurgery, Inc. (Palo Alto, CA); Co-founfer and CSO Glycosan Biosystems, Inc. Dr. Prestwich has published over 556 papers, patents, book chapters; he trained over 69 graduate students and 53 postdocs in 30 years.
Randall C. LaFevre, DVM
Vice President for Sale and Marketing
Dr. LaFevre has spent many years in the veterinary services business, holding significant positions in a number of veterinary companies. These included several key positions at Hill's Pet Nutrition, Director of Marketing and Professional Relations at PetSmart Veterinary Services, and for the last 10 years, Vice President for Professional Relations at Banfield, The Pet Hospital.
